MyoFlow
Telemonitoring system for myofunctional therapy that guides patients in real time and improves therapy efficiency.
← Back to works
CheckSkin
AI-powered computer vision system to distinguish between benign and malignant skin lesions, supporting early detection in dermatology.
Process
CheckSkin was developed with the Artificial Italianence Team to create a computer vision system capable of classifying skin lesions as benign or malignant. Using deep learning techniques, the system analyzes dermoscopic images and assists clinicians in early assessment of potentially dangerous skin conditions.
Outcome
The system achieved high classification performance, demonstrating the potential of AI to support dermatological diagnosis. CheckSkin helps clinicians make faster, more informed decisions, improving early detection and patient outcomes.
